Observation on the efficacy of early atomization inhalation of Budesonide under ventilator in the prevention of bronchopulmonary dysplasia in premature infants
HU Xiaojuan HU Feng DUAN Huiling#br#
Department of Neonatology,Jingdezhen Maternal and Child Health Hospital,Jiangxi Province,Jingdezhen 335000,China
Objective To explore the application value of early atomization inhalation of Budesonide under ventilator in the prevention of bronchopulmonary dysplasia (BPD)in premature infants.Methods The clinical data of 60 premature infants who needed ventilator treatment in Jingdezhen Maternal and Child Health Hospital from January 2020 to January 2023 were retrospectively analyzed.According to the different treatment methods,they were divided into control group (30 cases)and observation group(30 cases).The control group was treated with noninvasive ventilator assisted ventilation,and the observation group was treated with noninvasive ventilator assisted ventilation and early atomization inhalation of Budesonide under ventilator.The occurrence of BPD,treatment effect,pulmonary oxygenation index,inflammatory factors and adverse reactions were compared between the two groups.Results The incidence of BPD in the treatment group was lower than that in the control group,and the total oxygen inhalation time and ventilator use time were shorter than those in the control group,and the differences were statistically significant(P＜0.05).The oxygenation index(OI),alveolar-arterial oxygen partial pressure difference(PA-aO2),arterial partial pressure of carbon dioxide (PaCO2),tumor necrosis factor-α (TNF-α),interleukin(IL) -6,IL-8 and procalcitonin (PCT) in the treatment group were lower than those in the control group after 48 hours of treatment.The arterial partial pressure of oxygen (PaO2)in the observation group was higher than that in the control group,and the difference was statistically significant(P＜0.05).There were no adverse reactions in the two groups during treatment.Conclusion The application of early aerosol inhalation of budesonide under ventilator in premature infants can better improve their lung oxygenation indicators,shorten the total oxygen inhalation time and ventilator use time,reduce the levels of TNF-α,IL-6 and other inflammatory factors,and actively prevent the occurrence of BPD.It is safe and reliable,and has high clinical application value.
胡小娟 胡 枫 段会玲. 呼吸机下早期雾化吸入布地奈德预防早产儿支气管肺发育不良的疗效观察[J]. 中国当代医药, 2024, 31(16): 73-76转81.
HU Xiaojuan HU Feng DUAN Huiling. Observation on the efficacy of early atomization inhalation of Budesonide under ventilator in the prevention of bronchopulmonary dysplasia in premature infants. 中国当代医药, 2024, 31(16): 73-76转81.
Clauss C，Thomas S，Khodak I，et al.Hydrocortisone and bronchopulmonary dysplasia：variables associated with response in premature infants[J].J Perinatol，2020，40（9）：1349-1357.
[2]
Kwok TC，Sharkey D.Bedside assessment of pulmonary gas exchange in very preterm infants：a pathophysiological approach to bronchopulmonary dysplasia diagnosis?[J].Thorax，2021，76（7）：642-643.
Brewer MR，Maffei D，Cerise J，et al.Determinants of the lung microbiome in intubated premature infants at risk for bronchopulmonary dysplasia[J].J Matern Fetal Neonatal Med，2021，34（19）：3220-3226.
[7]
Cuna A，Lagatta JM，Savani RC，et al.Association of time of first corticosteroid treatment with bronchopulmonary dysplasia in preterm infants[J].Pediatr Pulmonol，2021，56（10）：3283-3292.
京公网安备 11010502046607号